EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance

Abhishek Chauhan, Anuj Ranjan, Neelam Mishra, Hardeep Singh Tuli, Ritu Chauhan, Damandeep Kaur, Laurent Dufossé, Naveen Chandra Joshi

Medicine in Drug Discovery · 2026-08 · 31 · 100259

DOI: 10.1016/j.medidd.2026.100259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine in Drug Discovery, 2026-08. Verfasst von Abhishek Chauhan und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyanobacteria are an evolutionarily ancient group of oxygenic photosynthetic prokaryotes recognized as prolific producers of structurally diverse secondary metabolites. Among these metabolites, peptides and polyketides constitute two major and classes of chemicals known for a broad-spectrum biological activities, viz. , antimicrobial, antiviral, anticancer, anti-inflammatory, enzyme inhibitory, and immunomodulatory effects. The chemical diversity of these compounds is primarily derived from non-ribosomal peptide synthetase (NRPS), polyketide synthase (PKS), and hybrid NRPS–PKS biosynthetic pathways, which enable the incorporation of non-proteinogenic amino acids, extensive tailoring reactions, and macrocyclization. In addition, ribosomally synthesized and post-translationally modified peptides (RiPPs) further expand the structural and functional repertoire of cyanobacterial natural products. This review provides a critical overview of cyanobacterial peptides and polyketides, focusing on their biosynthetic basis, structural diversity, and biological activities relevant to phytomedicine. Major peptide and polyketide scaffolds are discussed in relation to their molecular mechanisms of action and structure–activity relationships, with particular emphasis on applications in inflammation, cancer, infectious diseases, and immune modulation. Key challenges limiting translational application, including toxicity, low natural abundance, and cryptic biosynthetic gene clusters (BGCs), are also highlighted alongside emerging biotechnological strategies.

Zitieren

APA

Chauhan, A., Ranjan, A., Mishra, N., Tuli, H. S., Chauhan, R., Kaur, D., Dufossé, L., & Joshi, N. C. (2026). Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance. Medicine in Drug Discovery, 31, 100259. https://doi.org/10.1016/j.medidd.2026.100259

Vancouver

Chauhan A, Ranjan A, Mishra N, Tuli HS, Chauhan R, Kaur D, et al. Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance. Medicine in Drug Discovery. 2026;31:100259. doi:10.1016/j.medidd.2026.100259

BibTeX
@article{Chauhan2026,
  author = {Chauhan, Abhishek and Ranjan, Anuj and Mishra, Neelam and Tuli, Hardeep Singh and Chauhan, Ritu and Kaur, Damandeep and Dufossé, Laurent and Joshi, Naveen Chandra},
  title = {Cyanobacterial peptides and polyketides: biosynthetic basis, structural diversity and therapeutic relevance},
  journal = {Medicine in Drug Discovery},
  year = {2026},
  volume = {31},
  pages = {100259},
  doi = {10.1016/j.medidd.2026.100259}
}
Kostenlos starten →